Companion Diagnostic Tests in Oncology Market Report

Global and China Companion Diagnostic Tests in Oncology Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 05, 2022
  • PAGES：190
  • REPORT CODE：GMM1437266
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Companion Diagnostic Tests in Oncology industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Agendia

    • Agilent

    • QIAGEN

    • Siemens Healthcare

    • Illumina

    • Genomic Health

    • BioMerieux

    • Roche

    • Abbott

    • Thermo Fisher

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Protein Detection

    • DNA Detection

    Application:

    • Pharmaceutical & Biotechnology Companies

    • Medical Device Companies

    • Research Institutes

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Companion Diagnostic Tests in Oncology Industry Overview

      • 1.1.1 Companion Diagnostic Tests in Oncology Market Scope and Market Segments

      • 1.1.2 Companion Diagnostic Tests in Oncology Industry Characteristics

      • 1.1.3 Global and China Companion Diagnostic Tests in Oncology Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Companion Diagnostic Tests in Oncology Production Value and Growth Rate (2017-2028)

    • 1.2 Global Companion Diagnostic Tests in Oncology Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Protein Detection

      • 1.2.2 DNA Detection

    • 1.3 Global Companion Diagnostic Tests in Oncology Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Pharmaceutical & Biotechnology Companies

      • 1.3.2 Medical Device Companies

      • 1.3.3 Research Institutes

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Companion Diagnostic Tests in Oncology Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Companion Diagnostic Tests in Oncology Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Companion Diagnostic Tests in Oncology Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Companion Diagnostic Tests in Oncology Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Companion Diagnostic Tests in Oncology Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Companion Diagnostic Tests in Oncology Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Companion Diagnostic Tests in Oncology Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Companion Diagnostic Tests in Oncology Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Companion Diagnostic Tests in Oncology Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Companion Diagnostic Tests in Oncology Industry Porter's Five Forces Model Analysis

      • 2.2.3 Companion Diagnostic Tests in Oncology Industry PEST Analysis

    • 2.3 Companion Diagnostic Tests in Oncology Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Companion Diagnostic Tests in Oncology Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Companion Diagnostic Tests in Oncology Industry

    Chapter 3 Global and China Companion Diagnostic Tests in Oncology Market, by Manufacturer

    • 3.1 Global and China Companion Diagnostic Tests in Oncology Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Companion Diagnostic Tests in Oncology Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Companion Diagnostic Tests in Oncology Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Companion Diagnostic Tests in Oncology Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Companion Diagnostic Tests in Oncology Market Top 3 Players

    Chapter 4 Global and China Companion Diagnostic Tests in Oncology Market, by Type (2017-2028)

    • 4.1 Companion Diagnostic Tests in Oncology Market Trend, by Type

    • 4.2 Global Companion Diagnostic Tests in Oncology Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Companion Diagnostic Tests in Oncology Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Companion Diagnostic Tests in Oncology Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Companion Diagnostic Tests in Oncology Price Trend, by Type (2017-2028)

    • 4.3 China Companion Diagnostic Tests in Oncology Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Companion Diagnostic Tests in Oncology Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Companion Diagnostic Tests in Oncology Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Companion Diagnostic Tests in Oncology Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Companion Diagnostic Tests in Oncology Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Companion Diagnostic Tests in Oncology Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Companion Diagnostic Tests in Oncology Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Companion Diagnostic Tests in Oncology Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Companion Diagnostic Tests in Oncology Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Companion Diagnostic Tests in Oncology Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Companion Diagnostic Tests in Oncology Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Companion Diagnostic Tests in Oncology Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Companion Diagnostic Tests in Oncology Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Companion Diagnostic Tests in Oncology Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Companion Diagnostic Tests in Oncology Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Companion Diagnostic Tests in Oncology Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Companion Diagnostic Tests in Oncology Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Companion Diagnostic Tests in Oncology Market Analysis

    • 7.1 North America Companion Diagnostic Tests in Oncology Market, by Type

    • 7.2 North America Companion Diagnostic Tests in Oncology Market, by Application

    • 7.3 North America Companion Diagnostic Tests in Oncology Market Analysis and Forecast, by Country

      • 7.3.1 United States Companion Diagnostic Tests in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Companion Diagnostic Tests in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Companion Diagnostic Tests in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Companion Diagnostic Tests in Oncology Market Analysis

    • 8.1 Europe Companion Diagnostic Tests in Oncology Market, by Type

    • 8.2 Europe Companion Diagnostic Tests in Oncology Market, by Application

    • 8.3 Europe Companion Diagnostic Tests in Oncology Market Analysis and Forecast, by Country

      • 8.3.1 Germany Companion Diagnostic Tests in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Companion Diagnostic Tests in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Companion Diagnostic Tests in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Companion Diagnostic Tests in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Companion Diagnostic Tests in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Companion Diagnostic Tests in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Companion Diagnostic Tests in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Companion Diagnostic Tests in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Companion Diagnostic Tests in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Companion Diagnostic Tests in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Companion Diagnostic Tests in Oncology Market Analysis

    • 9.1 APAC Companion Diagnostic Tests in Oncology Market, by Type

    • 9.2 APAC Companion Diagnostic Tests in Oncology Market, by Application

    • 9.3 APAC Companion Diagnostic Tests in Oncology Market Analysis and Forecast, by Country

      • 9.3.1 China Companion Diagnostic Tests in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Companion Diagnostic Tests in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Companion Diagnostic Tests in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Companion Diagnostic Tests in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Companion Diagnostic Tests in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Companion Diagnostic Tests in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Companion Diagnostic Tests in Oncology Market Analysis

    • 10.1 Latin America, Middle East and Africa Companion Diagnostic Tests in Oncology Market, by Type

    • 10.2 Latin America, Middle East and Africa Companion Diagnostic Tests in Oncology Market, by Application

    • 10.3 Latin America, Middle East and Africa Companion Diagnostic Tests in Oncology Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Companion Diagnostic Tests in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Companion Diagnostic Tests in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Companion Diagnostic Tests in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Companion Diagnostic Tests in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Companion Diagnostic Tests in Oncology Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Companion Diagnostic Tests in Oncology Company Profiles

      • 11.1 Agendia

        • 11.1.1 Agendia Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Agendia Companion Diagnostic Tests in Oncology Product Profiles, Application and Specification

        • 11.1.3 Agendia Companion Diagnostic Tests in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Agilent

        • 11.2.1 Agilent Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Agilent Companion Diagnostic Tests in Oncology Product Profiles, Application and Specification

        • 11.2.3 Agilent Companion Diagnostic Tests in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 QIAGEN

        • 11.3.1 QIAGEN Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 QIAGEN Companion Diagnostic Tests in Oncology Product Profiles, Application and Specification

        • 11.3.3 QIAGEN Companion Diagnostic Tests in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Siemens Healthcare

        • 11.4.1 Siemens Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Siemens Healthcare Companion Diagnostic Tests in Oncology Product Profiles, Application and Specification

        • 11.4.3 Siemens Healthcare Companion Diagnostic Tests in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Illumina

        • 11.5.1 Illumina Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Illumina Companion Diagnostic Tests in Oncology Product Profiles, Application and Specification

        • 11.5.3 Illumina Companion Diagnostic Tests in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Genomic Health

        • 11.6.1 Genomic Health Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Genomic Health Companion Diagnostic Tests in Oncology Product Profiles, Application and Specification

        • 11.6.3 Genomic Health Companion Diagnostic Tests in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 BioMerieux

        • 11.7.1 BioMerieux Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 BioMerieux Companion Diagnostic Tests in Oncology Product Profiles, Application and Specification

        • 11.7.3 BioMerieux Companion Diagnostic Tests in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Roche

        • 11.8.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Roche Companion Diagnostic Tests in Oncology Product Profiles, Application and Specification

        • 11.8.3 Roche Companion Diagnostic Tests in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Abbott

        • 11.9.1 Abbott Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Abbott Companion Diagnostic Tests in Oncology Product Profiles, Application and Specification

        • 11.9.3 Abbott Companion Diagnostic Tests in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Thermo Fisher

        • 11.10.1 Thermo Fisher Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Thermo Fisher Companion Diagnostic Tests in Oncology Product Profiles, Application and Specification

        • 11.10.3 Thermo Fisher Companion Diagnostic Tests in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Companion Diagnostic Tests in Oncology Industry Investment Prospect and Risk Assessment

    • 12.1 Companion Diagnostic Tests in Oncology Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Companion Diagnostic Tests in Oncology Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Companion Diagnostic Tests in Oncology Sales Volume and Growth Rate (2017-2028)

    • Figure China Companion Diagnostic Tests in Oncology Sales Volume and Growth Rate (2017-2028)

    • Figure Global Companion Diagnostic Tests in Oncology Production Value and Growth Rate (2017-2028)

    • Figure China Companion Diagnostic Tests in Oncology Production Value and Growth Rate (2017-2028)

    • Figure Global Companion Diagnostic Tests in Oncology Market Size and Growth Rate of Protein Detection (2017-2028)

    • Figure Global Companion Diagnostic Tests in Oncology Market Size and Growth Rate of DNA Detection (2017-2028)

    • Figure Global Companion Diagnostic Tests in Oncology Market Size and Growth Rate of Pharmaceutical & Biotechnology Companies (2017-2028)

    • Figure Global Companion Diagnostic Tests in Oncology Market Size and Growth Rate of Medical Device Companies (2017-2028)

    • Figure Global Companion Diagnostic Tests in Oncology Market Size and Growth Rate of Research Institutes (2017-2028)

    • Figure North America Companion Diagnostic Tests in Oncology Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Companion Diagnostic Tests in Oncology Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Companion Diagnostic Tests in Oncology Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Companion Diagnostic Tests in Oncology Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Companion Diagnostic Tests in Oncology Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Companion Diagnostic Tests in Oncology Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Companion Diagnostic Tests in Oncology Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Companion Diagnostic Tests in Oncology Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Companion Diagnostic Tests in Oncology Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Companion Diagnostic Tests in Oncology Market Share, by Manufacturer in 2021

    • Figure Global and China Companion Diagnostic Tests in Oncology Market Share, by Manufacturer in 2022

    • Table Global Companion Diagnostic Tests in Oncology Sales Volume, by Type (2017-2028)

    • Table Global Companion Diagnostic Tests in Oncology Sales Volume Share, by Type (2017-2028)

    • Figure Global Companion Diagnostic Tests in Oncology Sales Volume Share, by Type (2017-2028)

    • Table Global Companion Diagnostic Tests in Oncology Sales Value, by Type (2017-2028)

    • Table Global Companion Diagnostic Tests in Oncology Sales Value Share, by Type (2017-2028)

    • Figure Global Companion Diagnostic Tests in Oncology Price Trend, by Type (2017-2028)

    • Table China Companion Diagnostic Tests in Oncology Sales Volume, by Type (2017-2028)

    • Table China Companion Diagnostic Tests in Oncology Sales Volume Share, by Type (2017-2028)

    • Figure China Companion Diagnostic Tests in Oncology Sales Volume Share, by Type (2017-2028)

    • Table China Companion Diagnostic Tests in Oncology Sales Value, by Type (2017-2028)

    • Table China Companion Diagnostic Tests in Oncology Sales Value Share, by Type (2017-2028)

    • Figure China Companion Diagnostic Tests in Oncology Price Trend, by Type (2017-2028)

    • Table Global Companion Diagnostic Tests in Oncology Sales Volume, by Application (2017-2028)

    • Table Global Companion Diagnostic Tests in Oncology Sales Volume Share, by Application (2017-2028)

    • Figure Global Companion Diagnostic Tests in Oncology Sales Volume Share, by Application (2017-2028)

    • Table Global Companion Diagnostic Tests in Oncology Sales Value, by Application (2017-2028)

    • Table Global Companion Diagnostic Tests in Oncology Sales Value Share, by Application (2017-2028)

    • Figure Global Companion Diagnostic Tests in Oncology Sales Value Share, by Application (2017-2028)

    • Table China Companion Diagnostic Tests in Oncology Sales Volume, by Application (2017-2028)

    • Table China Companion Diagnostic Tests in Oncology Sales Volume Share, by Application (2017-2028)

    • Figure China Companion Diagnostic Tests in Oncology Sales Volume Share, by Application (2017-2028)

    • Table China Companion Diagnostic Tests in Oncology Sales Value, by Application (2017-2028)

    • Table China Companion Diagnostic Tests in Oncology Sales Value Share, by Application (2017-2028)

    • Figure China Companion Diagnostic Tests in Oncology Sales Value Share, by Application (2017-2028)

    • Figure China Companion Diagnostic Tests in Oncology Production, Import, Consumption and Export (2017-2022)

    • Figure North America Companion Diagnostic Tests in Oncology Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Companion Diagnostic Tests in Oncology Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Companion Diagnostic Tests in Oncology Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Companion Diagnostic Tests in Oncology Production, Import, Consumption and Export (2017-2022)

    • Table North America Companion Diagnostic Tests in Oncology Sales Volume, by Type (2017-2028)

    • Table North America Companion Diagnostic Tests in Oncology Sales Volume Share, by Type (2017-2028)

    • Figure North America Companion Diagnostic Tests in Oncology Sales Volume Share, by Type (2017-2028)

    • Table North America Companion Diagnostic Tests in Oncology Sales Volume, by Application (2017-2028)

    • Table North America Companion Diagnostic Tests in Oncology Sales Volume Share, by Application (2017-2028)

    • Figure North America Companion Diagnostic Tests in Oncology Sales Volume Share, by Application (2017-2028)

    • Figure United States Companion Diagnostic Tests in Oncology Sales Volume and Growth Rate (2017-2028)

    • Figure United States Companion Diagnostic Tests in Oncology Sales Value and Growth Rate (2017-2028)

    • Figure Canada Companion Diagnostic Tests in Oncology Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Companion Diagnostic Tests in Oncology Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Companion Diagnostic Tests in Oncology Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Companion Diagnostic Tests in Oncology Sales Value and Growth Rate (2017-2028)

    • Table Europe Companion Diagnostic Tests in Oncology Sales Volume, by Type (2017-2028)

    • Table Europe Companion Diagnostic Tests in Oncology Sales Volume Share, by Type (2017-2028)

    • Figure Europe Companion Diagnostic Tests in Oncology Sales Volume Share, by Type (2017-2028)

    • Table Europe Companion Diagnostic Tests in Oncology Sales Volume, by Application (2017-2028)

    • Table Europe Companion Diagnostic Tests in Oncology Sales Volume Share, by Application (2017-2028)

    • Figure Europe Companion Diagnostic Tests in Oncology Sales Volume Share, by Application (2017-2028)

    • Figure Germany Companion Diagnostic Tests in Oncology Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Companion Diagnostic Tests in Oncology Sales Value and Growth Rate (2017-2028)

    • Figure UK Companion Diagnostic Tests in Oncology Sales Volume and Growth Rate (2017-2028)

    • Figure UK Companion Diagnostic Tests in Oncology Sales Value and Growth Rate (2017-2028)

    • Figure France Companion Diagnostic Tests in Oncology Sales Volume and Growth Rate (2017-2028)

    • Figure France Companion Diagnostic Tests in Oncology Sales Value and Growth Rate (2017-2028)

    • Figure Italy Companion Diagnostic Tests in Oncology Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Companion Diagnostic Tests in Oncology Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Companion Diagnostic Tests in Oncology Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Companion Diagnostic Tests in Oncology Sales Value and Growth Rate (2017-2028)

    • Figure Spain Companion Diagnostic Tests in Oncology Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Companion Diagnostic Tests in Oncology Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Companion Diagnostic Tests in Oncology Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Companion Diagnostic Tests in Oncology Sales Value and Growth Rate (2017-2028)

    • Figure Poland Companion Diagnostic Tests in Oncology Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Companion Diagnostic Tests in Oncology Sales Value and Growth Rate (2017-2028)

    • Figure Russia Companion Diagnostic Tests in Oncology Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Companion Diagnostic Tests in Oncology Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Companion Diagnostic Tests in Oncology Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Companion Diagnostic Tests in Oncology Sales Value and Growth Rate (2017-2028)

    • Table APAC Companion Diagnostic Tests in Oncology Sales Volume, by Type (2017-2028)

    • Table APAC Companion Diagnostic Tests in Oncology Sales Volume Share, by Type (2017-2028)

    • Figure APAC Companion Diagnostic Tests in Oncology Sales Volume Share, by Type (2017-2028)

    • Table APAC Companion Diagnostic Tests in Oncology Sales Volume, by Application (2017-2028)

    • Table APAC Companion Diagnostic Tests in Oncology Sales Volume Share, by Application (2017-2028)

    • Figure APAC Companion Diagnostic Tests in Oncology Sales Volume Share, by Application (2017-2028)

    • Figure China Companion Diagnostic Tests in Oncology Sales Volume and Growth Rate (2017-2028)

    • Figure China Companion Diagnostic Tests in Oncology Sales Value and Growth Rate (2017-2028)

    • Figure Japan Companion Diagnostic Tests in Oncology Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Companion Diagnostic Tests in Oncology Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Companion Diagnostic Tests in Oncology Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Companion Diagnostic Tests in Oncology Sales Value and Growth Rate (2017-2028)

    • Figure India Companion Diagnostic Tests in Oncology Sales Volume and Growth Rate (2017-2028)

    • Figure India Companion Diagnostic Tests in Oncology Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Companion Diagnostic Tests in Oncology Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Companion Diagnostic Tests in Oncology Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Companion Diagnostic Tests in Oncology Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Companion Diagnostic Tests in Oncology Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Companion Diagnostic Tests in Oncology Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Companion Diagnostic Tests in Oncology Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Companion Diagnostic Tests in Oncology Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Companion Diagnostic Tests in Oncology Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Companion Diagnostic Tests in Oncology Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Companion Diagnostic Tests in Oncology Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Companion Diagnostic Tests in Oncology Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Companion Diagnostic Tests in Oncology Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Companion Diagnostic Tests in Oncology Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Companion Diagnostic Tests in Oncology Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Companion Diagnostic Tests in Oncology Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Companion Diagnostic Tests in Oncology Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Companion Diagnostic Tests in Oncology Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Companion Diagnostic Tests in Oncology Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Companion Diagnostic Tests in Oncology Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Companion Diagnostic Tests in Oncology Sales Value and Growth Rate (2017-2028)

    • Table Agendia Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Agendia Product Profiles, Application and Specification

    • Table Agendia Companion Diagnostic Tests in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Agilent Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Agilent Product Profiles, Application and Specification

    • Table Agilent Companion Diagnostic Tests in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table QIAGEN Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table QIAGEN Product Profiles, Application and Specification

    • Table QIAGEN Companion Diagnostic Tests in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Siemens Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Siemens Healthcare Product Profiles, Application and Specification

    • Table Siemens Healthcare Companion Diagnostic Tests in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Illumina Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Illumina Product Profiles, Application and Specification

    • Table Illumina Companion Diagnostic Tests in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Genomic Health Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Genomic Health Product Profiles, Application and Specification

    • Table Genomic Health Companion Diagnostic Tests in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table BioMerieux Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table BioMerieux Product Profiles, Application and Specification

    • Table BioMerieux Companion Diagnostic Tests in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Roche Product Profiles, Application and Specification

    • Table Roche Companion Diagnostic Tests in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Abbott Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abbott Product Profiles, Application and Specification

    • Table Abbott Companion Diagnostic Tests in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Thermo Fisher Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Thermo Fisher Product Profiles, Application and Specification

    • Table Thermo Fisher Companion Diagnostic Tests in Oncology Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US